Pelareorep Completed Phase 2 Trials for Ewing's Sarcoma / Synovial Sarcomas / Malignant Fibrous Histiocytoma / Fibrosarcoma / Leiomyosarcoma (LMS) / Osteosarcoma Treatment

Indications	Status	Purpose	Phase
DBCOND0028085 (Ewing's Sarcoma) DBCOND0167622 (Synovial Sarcomas) DBCOND0036118 (Malignant Fibrous Histiocytoma) DBCOND0016192 (Fibrosarcoma) DBCOND0118909 (Leiomyosarcoma (LMS)) DBCOND0016214 (Osteosarcoma)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00503295	Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung	Pelareorep (DB17284)